| Financial Year |
March 31 2023 |
| Monetary Funds |
856,298,851.08 |
| Held-for-trading Financial Assets |
31,929,635.99 |
| Notes Receivable |
789,000.00 |
| Accounts Receivable |
2,039,905,255.99 |
| Advances to Suppliers |
87,406,860.46 |
| Other Receivables |
153,467,936.52 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
3,392,543.51 |
| Inventories |
488,351,208.19 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
61,664,421.32 |
| Total Current Assets |
4,324,787,330.22 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
283,126,690.08 |
| Long-term Equity Investment |
364,295,261.56 |
| Investment Properties |
-- |
| Fixed Assetes |
502,031,590.10 |
| Under-construction Projects |
62,873,313.78 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
2,546,150.16 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
208,985,816.60 |
| R&D expenses |
67,688,651.71 |
| Goodwill |
93,186,577.68 |
| Long-Term Deferred and Prepaid Expenses |
11,820,846.81 |
| Deferred Income Tax Assets |
65,462,047.08 |
| Other Non-Current Assets |
689,454,062.58 |
| Sub-Total of Non-Current Assets |
2,435,293,330.41 |
| Total Assets |
6,760,080,660.63 |
| Short-Term Loans |
638,561,055.41 |
| Trading Financial liabilities |
-- |
| Notes Payable |
128,646,040.52 |
| Accounts Payable |
1,401,457,200.71 |
| Accounts Received In Advance |
382,288.00 |
| Employee Compensation Payable |
19,515,753.92 |
| Taxes Payable |
49,351,391.58 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
141,574,823.96 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
196,372,197.35 |
| Other Current Liabilities |
59,445,750.37 |
| Sub-Total of Current Liabilities |
2,809,755,615.62 |
| Long-term Loans |
797,150,132.87 |
| Bonds Payable |
550,947,516.18 |
| Long-Term Accounts Payable |
109,548,489.69 |
| Special Payable |
-- |
| Estimatied Liabilities |
4,446,536.86 |
| Deferred Income Tax Liabilities |
4,971,048.83 |
| Other Non-Current Liabilities |
43,637,176.22 |
| Sub-Total of Non-Current Liabilities |
1,600,384,209.17 |
| Total Liabilities |
4,410,139,824.79 |
| Paid-In Capital(Or Share Stock) |
861,960,075.00 |
| Capital Surplus |
494,296,045.60 |
| Surplus Reserve |
72,251,609.78 |
| LESS:Treasury Stock |
30,064,977.50 |
| Undistributed Profits |
488,060,260.32 |
| Minority Stockholder's Interest |
305,407,093.50 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,044,533,742.34 |
| Owner's Equity（Stockholder's Equity） |
2,349,940,835.84 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,760,080,660.63 |
